Company Filing History:
1 out of 4,814 
1 out of 16 
Years Active: 2020
Title: The Contributions of Bernhard Stockmeyer in Medical Innovation
Introduction
Bernhard Stockmeyer is a noted inventor based in Erlangen, Germany, recognized for his significant contributions to the field of biotechnology. With a focus on medical innovations, he has developed a patent that aims to enhance treatment methodologies for specific diseases, including types of cancer.
Latest Patents
Bernhard Stockmeyer's prominent patent is titled "Anti-CD89 cytotoxic complex." This innovative complex is designed for targeting and killing human target cells. It comprises a first polypeptide with a binding structure for adherence to the CD89 cellular surface receptor and a second polypeptide possessing a toxic effector domain, specifically exotoxin A. His intellectual property also encompasses nucleic acid molecules encoding these complexes, vectors, and host cells that contain the nucleic acids. Moreover, he has developed compositions and methods for utilizing these complexes in the treatment of diseases, particularly leukemia.
Career Highlights
Throughout his career, Stockmeyer has worked with esteemed institutions, contributing his expertise to advance research and development. Notably, he has been associated with the Fraunhofer Society for the Advancement of Applied Research and the RWTH Aachen University. His work at these institutions highlights his impact on the scientific community and his commitment to innovative medical solutions.
Collaborations
In the course of his professional journey, Bernhard Stockmeyer has collaborated with colleagues such as Christoph Stein and Radoslav Mladenov. These partnerships reflect his ability to work effectively in a collaborative research environment, fostering innovation through shared knowledge and expertise.
Conclusion
In summary, Bernhard Stockmeyer stands out as an inventive force in the realm of biotechnology, particularly with his patented Anti-CD89 cytotoxic complex. His dedication to medical research and innovation continues to pave the way for advanced treatments in cancer care. As he progresses in his career, his contributions are likely to inspire future breakthroughs in medical science.